Department of Dermatology, Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.
Mental Health Department, Guelph General Hospital, Guelph, Ontario, Canada.
J Cosmet Dermatol. 2022 Nov;21(11):5405-5408. doi: 10.1111/jocd.15160. Epub 2022 Jun 25.
Female Pattern Hair Loss (FPHL) is one of the most common types of hair loss in women. It is characterized by progressive follicular miniaturization leading to diffuse hair thinning over the midfrontal scalp with a negative impact on quality of life. Pharmacological treatments are commonly used, and hair follicle transplantation is an option for those cases with adequate donor area. Minimally invasive procedures, such as microneedling, mesotherapy, microinfusion of drugs into the scalp with tattoo machines (MMP®), and platelet-rich plasma (PRP) have been reported as adjuvant treatments.
This study aims to summarize and discuss the efficacy of minimally invasive procedures described for the management of FPHL.
Published articles indexed on the Pubmed database and Scopus that described minimally invasive procedures for the management of FPHL in humans were considered. Citations were reviewed and added for completeness. The search was for articles in English only. After excluding duplicate titles, 23 relevant articles were considered.
Minimally invasive procedures are promising options and may play a role in FPHL treatment. They can be used as adjunctive therapy for FPHL, in case of poor response to clinical therapy, or when patients prefer other care than the standard. We reinforce that these methods should be performed by an experienced medical professional following strict aseptic techniques. However, microneedling, mesotherapy, MMP, and PRP lack standardization and are supported by a low level of evidence yet. For the future, larger randomized clinical trials are essential to determine the efficacy and optimal protocols for these treatments.
女性型脱发(FPHL)是女性最常见的脱发类型之一。其特征是进行性毛囊微小化,导致额中部头皮弥漫性头发变细,从而对生活质量产生负面影响。通常使用药物治疗,对于有足够供体区的病例,毛发移植是一种选择。微创程序,如微针、中胚层疗法、用纹身机将药物微注入头皮(MMP®)和富血小板血浆(PRP),已被报道为辅助治疗。
本研究旨在总结和讨论描述用于治疗 FPHL 的微创程序的疗效。
考虑了在 Pubmed 数据库和 Scopus 上索引的描述用于人类 FPHL 管理的微创程序的已发表文章。为完整性起见,对引用进行了审查和添加。仅搜索英文文章。排除重复标题后,考虑了 23 篇相关文章。
微创程序是有前途的选择,可能在 FPHL 治疗中发挥作用。它们可以作为 FPHL 治疗的辅助疗法,用于临床治疗反应不佳的病例,或当患者更喜欢标准治疗以外的其他护理时。我们强调,这些方法应由经验丰富的医疗专业人员在严格的无菌技术下进行。然而,微针、中胚层疗法、MMP 和 PRP 缺乏标准化,并且证据水平较低。未来,需要更大规模的随机临床试验来确定这些治疗的疗效和最佳方案。